Thrivent Financial for Lutherans’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-50,139
Closed -$1.15M 2550
2020
Q4
$1.15M Hold
50,139
﹤0.01% 1660
2020
Q3
$1.26M Sell
50,139
-2,995
-6% -$81.8K ﹤0.01% 1435
2020
Q2
$1.48M Hold
53,134
﹤0.01% 1238
2020
Q1
$309K Buy
+53,134
New +$483K ﹤0.01% 1965

Other funds holding MGNX

Thrivent Financial for Lutherans's MGNX Position: Q1 2021 in Review

Thrivent Financial for Lutherans sold out of MacroGenics (MGNX) in Q1 2021, closing a stake of 50,139 shares — an estimated $1.15M sold.

Thrivent Financial for Lutherans first reported a position in MGNX in Q1 2020 and held it in 4 quarters. The position peaked at $1.48M in Q2 2020. 173 funds tracked by Wall St. Rank hold MGNX as of Q1 2021.

  • Thrivent Financial for Lutherans reported no remaining MacroGenics position as of Q1 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 50,139 MacroGenics shares in Q1 2021, an estimated $1.15M.
  • Thrivent Financial for Lutherans first reported a position in MacroGenics in Q1 2020 and held it in 4 quarters.
  • Thrivent Financial for Lutherans's MacroGenics position peaked at $1.48M in Q2 2020.
  • 173 funds tracked by Wall St. Rank held MacroGenics as of Q1 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2021, filed 17 May 2021.